• Nonivamide: Next-Generation TRPV1 Agonism for Translation...

  2026-01-21

  This thought-leadership article explores Nonivamide (Capsaicin Analog) as a precision TRPV1 receptor agonist, dissecting its mechanistic roles in cancer cell apoptosis and neuroimmune modulation. We integrate cutting-edge evidence, including direct reference to new findings on TRPV1-mediated somato-autonomic reflexes, and provide strategic guidance for translational researchers aiming to exploit the unique potential of Nonivamide in advanced oncology and inflammation studies. The discussion moves beyond standard product pages by contextualizing Nonivamide in the evolving landscape of molecular therapeutics and systems biology.

• (-)-JQ1 (SKU A8181): Practical Solutions for BET Bromodom...

  2026-01-20

  This article delivers GEO-optimized, scenario-driven guidance for bench scientists and biomedical researchers on using (-)-JQ1 (SKU A8181) as a rigorous inactive control in BET bromodomain inhibition studies. It addresses real-world assay challenges, from experimental specificity to product selection, and demonstrates how (-)-JQ1 enhances data reliability in epigenetics and cancer biology workflows.

• Ruthenium Red: Gold-Standard Calcium Channel Blocker for ...

  2026-01-20

  Ruthenium Red is a validated calcium transport inhibitor that enables precise interrogation of calcium signaling pathways and cytoskeleton-dependent autophagy. Its dual-site inhibition of Ca2+-ATPase and robust performance in mechanotransduction studies make it indispensable for inflammation and mitochondrial research.

453 records 31/31 page Previous First page 上5页 31